145 related articles for article (PubMed ID: 7921203)
21. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
[TBL] [Abstract][Full Text] [Related]
22. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
Jose A; Kaplan NM
Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
[No Abstract] [Full Text] [Related]
23. [A case of idiopathic hyperaldosteronism with normal plasma aldosterone concentrations for 5 years after onset: a 12-year follow-up study].
Nemoto T; Niimura S; Hayashi A; Gomibuchi T; Sanada H; Watanabe Y; Shigetomi S; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1994 May; 70(4):439-46. PubMed ID: 7958093
[TBL] [Abstract][Full Text] [Related]
24. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
[TBL] [Abstract][Full Text] [Related]
25. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
[No Abstract] [Full Text] [Related]
26. Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia.
Ganguly A; Melada GA; Luetscher JA; Dowdy AJ
J Clin Endocrinol Metab; 1973 Nov; 37(5):765-75. PubMed ID: 4356136
[No Abstract] [Full Text] [Related]
27. The occurrence of hyperaldosteronism in infants with congestive heart failure.
Baylen BG; Johnson G; Tsang R; Srivastava L; Kaplan S
Am J Cardiol; 1980 Feb; 45(2):305-10. PubMed ID: 6986745
[TBL] [Abstract][Full Text] [Related]
28. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Gill JR; Bartter FC
J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
[TBL] [Abstract][Full Text] [Related]
29. Influence of unilateral adrenalectomy on renin-angiotensin-aldosterone system in primary aldosteronism.
Kawasaki T; Uezono K; Ueno M; Noda Y; Kumamoto K; Kawano Y; Ogata M; Fukiyama K; Omae T; Bartter FC
Jpn Heart J; 1980 Sep; 21(5):681-92. PubMed ID: 7001091
[TBL] [Abstract][Full Text] [Related]
30. Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Vetter H; Siebenschein R; Studer A; Witassek F; Furrer J; Glänzer K; Siegenthaler W; Vetter W
Acta Endocrinol (Copenh); 1978 Dec; 89(4):710-25. PubMed ID: 213920
[TBL] [Abstract][Full Text] [Related]
31. Spironolactone as a nonspecific treatment for primary aldosteronism.
Bravo EL; Dustan HP; Tarazi RC
Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
[No Abstract] [Full Text] [Related]
32. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of the post-captopril test in primary aldosteronism.
Castro OL; Yu X; Kem DC
Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
Hood S; Cannon J; Foo R; Brown M
Clin Med (Lond); 2005; 5(1):55-60. PubMed ID: 15745200
[TBL] [Abstract][Full Text] [Related]
35. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
[TBL] [Abstract][Full Text] [Related]
36. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
38. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
39. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Schwartz GL; Turner ST
Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
[TBL] [Abstract][Full Text] [Related]
40. Diuretics and bone loss in rats with aldosteronism.
Law PH; Sun Y; Bhattacharya SK; Chhokar VS; Weber KT
J Am Coll Cardiol; 2005 Jul; 46(1):142-6. PubMed ID: 15992648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
